http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0432899-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 |
filingDate | 1990-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70ea7781a66493541cb1ac3fa51bd1b5 |
publicationDate | 1991-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0432899-A1 |
titleOfInvention | Novel pharmaceutical epinephrine-pilocarpine derivatives |
abstract | The present invention relates to new racemic and optically active compounds containing a first moiety derived from a pilocarpine compound in which the furanone ring of pilocarpine is replaced by a hetero-ring containing a secondary nitrogen heteroatom, and a second moiety derived from an epinephrine compound or a β-adrenergic blocking compound, linked at the secondary nitrogen atom of the furanone-replacing hetero-ring of the pilocarpine compound and at the hydroxyl group of the epinephrine compound or of the β-adrenergic blocking compound, via a carbonyl linker, and pharmaceutically acceptable acid addition salts thereof. n The new compounds of the present invention are potent ocular hypotensives exhibiting minimal deleterious pupillary effects. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5484780-A |
priorityDate | 1989-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 161.